DELRAY BEACH, Fla., March 21, 2025 /PRNewswire/ — The global US Healthcare Analytics Market, valued at US$15.84 billion in 2024, is forecasted to grow at a robust CAGR of 24.5%, reaching US$47.40 billion by 2029. The major factors driving the market growth of the healthcare analytics in the US include growing pressure to curb healthcare spending, increasing demand to improve patient outcomes, and the rising focus on real-world evidence. The Centers for Medicare & Medicaid Services (CMS) projects that from 2023 to 2032, National Health Expenditures will grow at an average annual rate of 5.6%, outpacing GDP growth (4.3%), increasing the health spending share of GDP from 17.3% in 2022 to 19.7% by 2032. The healthcare analytics help to curb this rising healthcare costs by enabling data-driven decision-making, predictive modeling, fraud detection, and optimized resource utilization, reducing unnecessary procedures, hospital readmissions, and inefficiencies in care delivery.
MarketsandMarkets Logo
Moreover, several venture capitalists are currently funding US based healthcare analytics startups. For instance, in 2023, US venture capital investments in AI healthcare companies totalled USD 7.2 billion, accounting for 21% of total VC healthcare investment.
Download PDF Brochure:
Browse in-depth TOC on “US Healthcare Analytics Market“
150 – Tables 50 – Figures
Based on type, the descriptive analytics segment is projected to account for the largest share of US healthcare analytics market in 2023.
The rising need for data-driven decision-making based on historical trends is a key factor propelling the market growth. To extract meaningful insights from past data, organizations increasingly rely on descriptive analytics which further allows them to gain several advantages such as comprehensive understanding of present market conditions and operational performance, improve strategic planning, resource allocation optimization and enhance customer engagement by recognizing key patterns and trends, thereby, driving the market growth.
Based on application, the clinical analytics segment is projected to account for the largest share of US healthcare analytics market in 2023.
The growing adoption of Electronic Health Records, along with the improve decision-making abilities and recent technological advancements, is significantly boosting the demand for clinical analytics in US. For instance, in January 2024, Amalgam Rx (US) announced the acquisition of Avhana Health (US), an EHR-integrated clinical decision support (CDS) software company to aid expansion of Avhana’s CDS tools across more therapeutic areas and integrate them with its digital solutions to streamline doctors’ workflows. Hence, such developments designed to streamline therapeutic processes are responsible for the market growth.
Based on end user, the provider segment is expected to grow at the fastest CAGR in the US healthcare analytics market during the forecast period.
The shift towards value-based care, regulatory mandates, and digital transformation is propelling the market growth. Providers such as hospitals & clinics, ambulatory surgery centers, post-acute care organizations, among others are increasingly adopting AI, ML, and cloud-based analytics to boost patient outcomes and operational efficiency. For instance, in September 2023, SAS Institute Inc. (US) developed a comprehensive, advanced analytical solution for healthcare providers known as SAS Health which improve health data management and analytics through the incorporation of AI and ML ultimately aiming to improve patient outcomes and operational efficiency.
Request Sample Pages :
The report profiles key players such as Merative (US), Optum, Inc. (US), SAS Institute Inc. (US), Oracle (US), Citiustech Inc (US), Inovalon (US), Mckesson Corporation (US), MedeAnalytics, Inc. (US), Cotiviti, Inc. (US).
For more information, Inquire Now!
Related Reports:
Wearable Technology Market
Patient Monitoring Devices Market
Pulse Oximeter Market
Diagnostic Electrocardiograph Market
Fetal Monitoring Market
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
In addition, MarketsandMarkets SalesIQ enables sales teams to identify high-priority accounts and uncover hidden opportunities, helping them build more pipeline and win more deals with precision.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445 USA: +1-888-600-6441 Email: [email protected] Visit Our Website:
